CBIS LATEST NEWS.

2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009


Dr. Sulma Mohammed

Sulma I. Mohammed DVM, MS, PhD

- Member of Scientific Advisory Board


Dr. Sulma Mohammed is an Associate Professor of Cancer Biology at the Department of Comparative Pathobiology, Purdue Center for Cancer Research, and Indiana University School of Medicine, Indiana, USA. Dr. Mohammed has acquired extensive knowledge of basic and applied medical sciences, molecular biology, cell biology, biochemistry, and microbiology through her graduate programs at Cornell University and Purdue University as well as experience in cancer research from the basic level to pre-clinical research in animal models and human clinical trials. As Director of Purdue Cancer Center Drug Discovery Shared Resource (2002-2007), she had provided high quality service to members of the Cancer Center, developed protocols and consulted on the design and implementation of in vitro and in vivo experiments. In addition, she devoted much effort to characterization of a unique animal model, which develops spontaneous pre-malignant lesions very similar to humans’ lesions in all morphological, molecular, and clinical diversity. In addition, her laboratory interested in understanding breast cancer metastasis through the lymphatic system. To do so, Dr. Mohammed secured research funding as a principal investigator as well as a co-investigator through extramural grants from federal agencies and foundations, including the National Cancer Institute/National Institutes of Health, the United States Department of Defense, the Showalter Trust Fund, and industry funding sources. Dr. Mohammed has been the principal author, co-author, or senior author of 75 peer-reviewed articles, 84 abstracts, presentations, and commissioned editorials, 34 invited talks, and 3 book chapters. Dr. Mohammed is also a member of the African Diaspora Health Initiative (ADHI) Executive Committee. Dr. Mohammed is a recipient of many awards, including an award from Walther Cancer Institute; the American Association for Cancer Research-Cancer research Foundation of America fellowship in Prevention Research award; the AACR Minority Scholar Award in Cancer Research; and the National Cancer Institute (NIH) fellowship. Dr. Mohammed is also the recipient of a Certificate of Appreciation for Excellence and Leadership in the Field of Breast Cancer and Health Awareness in African countries. Mohammed serves as a council member of the African Organization for Research and Training in Cancer (AORTIC) and she was the former Vice-President of North America region. She, along with her African colleagues, reactivated the AORTIC, a non-governmental organization that is dedicated to the promotion of cancer control, increasing public awareness and reducing the stigma associated with cancer.

 

Dr. Joe Wilson

Dr. Joe Wilson

- Member of International Government Affairs Board


Dr. Wilson is the founder and Chief Executive Officer for CyberEnginuity LLC. Dr. Wilson founded the parent company (TelcoCapital) in 2002 in Seattle, WA. Joe has been an information technology and IT security professional for over 20 years. His background includes senior systems engineer at Boeing Commercial Airplane Company in Seattle Washington, where he was responsible for designing secure air to ground communications systems and cryptographically secure network management systems. At the Microsoft Corporation, Joe was a consulting engineer for Tata Consultancy (Redmond Washington). Tata Consultancy Group is a global enterprise headquartered in India, and comprises over 100 operating companies, with operations in more than 100 countries across six continents, exporting products and services to over 150 countries. Joe retired from The Boeing Company in 2009.

Dr. Wilson is a summa cum laude Ph.D. graduate from Capella University (Minneapolis, MN), majoring in information technology and cybersecurity. Joe is a Certified Information Systems Security Professional (CISSP) in good standings with (ISC)2, and has a post masters certification in college teaching. Joe has been an associate college professor for sixteen years, and currently teaches online courses for the Masters of Science in Cybersecurity program at Liberty University (Lynchburg, VA).

As an IT Security and Risk Management professional, Dr. Wilson provides leadership for the ongoing evolution of organizations’ regulatory compliance programs. His recent client was recognize by a leading industry auditor to be a national leader among similar businesses in designing and maintaining mature compliance management programs in the areas of ISO 27002, NIST-800, GLBA, HIPPA, HITRUST, PCI-DSS, Nevada NRS 603a, Massachusetts 201 CMR 17.00, FTC Red Flags Rule, and the NY Cybersecurity Requirements for Financial Organizations.

Joe is passionate about promoting the adoption and use of information technology security standards and measurements inside public and private organizations. He has been an active participant with the development of the National Institute of Standards and Technology NIST Cybersecurity Framework. This project was commissioned by the U.S. Department of Commerce under Executive Order 13636. The NIST Cybersecurity Framework provides a policy based approach for computer security guidance on how organizations in the U.S. and other countries can assess and improve their ability to prevent, detect, and respond to cyber attacks. The Framework has gained wide acceptance and adoption world-wide.

Joe is the founder of Innovative Blockchain LLC (Inoblockchain), which provides education, training and consulting services for emerging blockchain applications.

As a military veteran Dr. Wilson provides volunteer services to the American Red Cross to assist veterans’ transition into cybersecurity careers. Dr. Wilson successfully completed the JATC Apprenticeship program in Las Vegas prior to joining the U.S. Military. Dr. Wilson currently teaches online courses in Liberty University’s online Masters of Science in Cybersecurity program. He is an honary member of the Kappa Delta Pi, International Honor Society in Education.

Dr. Jermane Bond

- Member of The Scientific Advisory Board


Dr. Bond was recently appointed Assistant Research Professor in the Department of Prevention and Community Health at the Milken Institute School of Public Health, The George Washington University. He is also a Senior Fellow at the National Collaborative for Health Equity and Co-Founder, Health Equity Analytics Lab (HEAL, LLC), a health analytics firm and Advocates for Men's Health, a national campaign to improve life expectancy for men in the District of Columbia.

His research portfolio includes men’s preconception health and reproductive life planning, paternal involvement in pregnancy outcomes and disparities in maternal and child health (MCH). In 2009, with funding from the Office of Minority Health in the Department of Health and Human Services, he formed and directed the Commission on Paternal Involvement in Pregnancy Outcomes, (a transdisciplinary working group of social scientist and public health professionals) to raise awareness for the importance of paternal involvement in pregnancy and family health by reframing debates, informing research, policy and practice to support greater involvement of expectant fathers in pregnancy.

In 2017 he concluded a six-year term of service on the Editorial Board of the American Journal of Public Health. As a long-standing member of the American Public Health Association, he founded and currently chairs the maternal and child health (MCH) Section’s Paternal Involvement in Pregnancy Outcomes Committee. He also serves as an Associate Editor for BMC Pregnancy and Childbirth and sits on other Editorial Boards including the Maternal and Child Health Journal, Reproductive Systems & Sexual Disorders and Clinical Medicine Insights: Reproductive Health. Dr. Bond received a B.A. from Morehouse College, and a Ph.D. from Howard University.

Dr. Jermane Bond

- Member of The Scientific Advisory Board


Dr. Bond was recently appointed Assistant Research Professor in the Department of Prevention and Community Health at the Milken Institute School of Public Health, The George Washington University. He is also a Senior Fellow at the National Collaborative for Health Equity and Co-Founder, Health Equity Analytics Lab (HEAL, LLC), a health analytics firm and Advocates for Men's Health, a national campaign to improve life expectancy for men in the District of Columbia.

His research portfolio includes men’s preconception health and reproductive life planning, paternal involvement in pregnancy outcomes and disparities in maternal and child health (MCH). In 2009, with funding from the Office of Minority Health in the Department of Health and Human Services, he formed and directed the Commission on Paternal Involvement in Pregnancy Outcomes, (a transdisciplinary working group of social scientist and public health professionals) to raise awareness for the importance of paternal involvement in pregnancy and family health by reframing debates, informing research, policy and practice to support greater involvement of expectant fathers in pregnancy.

In 2017 he concluded a six-year term of service on the Editorial Board of the American Journal of Public Health. As a long-standing member of the American Public Health Association, he founded and currently chairs the maternal and child health (MCH) Section’s Paternal Involvement in Pregnancy Outcomes Committee. He also serves as an Associate Editor for BMC Pregnancy and Childbirth and sits on other Editorial Boards including the Maternal and Child Health Journal, Reproductive Systems & Sexual Disorders and Clinical Medicine Insights: Reproductive Health. Dr. Bond received a B.A. from Morehouse College, and a Ph.D. from Howard University.

Raymond C. Dabney

Raymond C. Dabney

- President & CEO, Co-Founder and Director


Mr. Raymond C. Dabney, President & CEO, brings 25 years of experience in corporate finance, corporate structure, corporate communications, sales and marketing for public companies. Mr. Dabney has significant experience in public and private venture capital, early stage equity/debt financings and regulatory compliance.

Mr. Dabney has co-founded several public and private companies in many diverse industries such as drug development, entertainment, media, advertising, mining, automobile, high-tech, manufacturing, real estate and communications, many of which he launched from day one. Cannabis Science is a prime example of the type of organizations that Mr. Dabney has built from inception. Mr. Dabney has extensive international relationships that he has utilized to grow each Company, from the US, Canada, several European centers, such as Paris, London, Amsterdam and eastern Spain, as well as countries in the West Indies, South America, and Asia. Mr. Dabney’s niche market knowledge, team leadership, and management style facilitate the continued growth and forward thinking that successfully bring his projects from concept to completion.

In March 2018 Mr. Dabney was presented the prestigious Industry Leader Award by the GHC Summit Organizing Committee at the Global Health Catalyst Summit at Harvard University. Mr. Dabney was presented this award for “…establishing groundbreaking partnerships with African institutions to close the cancer and pain divide, investigating safe phytomedicine alternatives to opioids, and providing support for the development of phytomedicines to reduce global health disparities.”